Biología molecular del cáncer
Queen's University Belfast
Belfast, Reino UnidoPublicacions en col·laboració amb investigadors/es de Queen's University Belfast (4)
2022
-
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Critical Care, Vol. 26, Núm. 1
2007
2006
-
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: The X-ACT trial
British Journal of Cancer, Vol. 94, Núm. 8, pp. 1122-1129
2002
-
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)
European Journal of Cancer, Vol. 38, Núm. 11, pp. 1429-1436